Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ingrid M. Nijholt has a total of 179 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early versus delayed trial without catheter in men with Acute urinary retention - Study Protocol for a dutch national randomized trial

    by Liselot L.A. Ribbert, Nadine A.M. van Merode, Marco H. Blanker, Michelle M.A. Kip, Ingrid M. Nijholt, Lambertus P.W. Witte

    Introduction: Acute urinary retention (AUR) is a burdensome urological emergency, often caused by benign prostatic obstruction. Standard management includes transurethral catheterization, alpha-blocker therapy, and a trial without catheter (TWOC) to assess spontaneous voiding. Despite the high incidence of AUR, the optimal catheter duration prior to TWOC remains uncertain. Evidence is limited, guideline recommendations are largely expert-based, and catheter duration varies widely in practice. Prolonged catheterization may increase morbidity and discomfort, whereas earlier removal may raise concerns regarding recurrent retention. Methods: RELIEF is a pragmatic, multicenter, randomized non-inferiority trial comparing TWOC on day 3 versus TWOC on day 14 in men with AUR. All participants undergo transurethral catheterization and receive alpha-blocker therapy prior to randomization. Primary outcome is TWOC success, defined as a voided volume ≥100 mL and post-void residual ≤200 mL. The primary analysis follows a per-protocol approach, with a complementary intention-to-treat analysis to confirm non-inferiority. Secondary outcomes include recurrent retention, catheter-related complications, patient-reported symptoms and quality of life, and cost-effectiveness from healthcare and societal perspectives over 18 months. In parallel, a qualitative substudy using semi-structured interviews with healthcare professionals aims to explore the determinants underlying current practice variation, as well as the perceived barriers and facilitators for the sustainable implementation of a standardized TWOC strategy in future clinical practice. Discussion: By comparing two catheterization intervals already applied in routine care and combining clinical, patient-reported, economic, and implementation outcomes, RELIEF is designed to generate directly applicable evidence on TWOC timing after AUR. The results are expected to support guideline refinement and improve consistency of care. Trial registration: WHO ICTRP primary registry, identifier NL-OMON57836. Registered on February 7, 2025.

  • Radiologists’ evaluation of synthetic cervical spine CT in addition to MR and X-ray imaging for radiculopathy

    by Gaby J. van Den Wittenboer, Ingrid M. Nijholt, Britt Y.M. van der Kolk, Boudewijn A.A.M. van Hasselt, Henk J. Boelhouwers, Laura W. de Jong, Mario Maas, Martijn F. Boomsma

  • Short Antibiotic Treatment for Coagulase-negative Staphylococcal Sepsis in Premature Infants: A Multicenter Noninferiority Study

    by Esther J. D’HAens, Sylvia B. Debast, John W.A. Rossen, Douwe H. Visser, Klasien A. Bergman, Jacqueline U.M. Termote, Tom F.W. Wolfs, Yvette G.T. Loeffen, Matthias C. Hutten, Carmen Lorente Flores, et al.

    Background: Optimizing antibiotic duration in neonatal intensive care units is essential for antimicrobial stewardship and microbiome preservation. However, the safety of short antibiotic courses for uncomplicated late-onset coagulase-negative staphylococcal (CoNS) sepsis remains uncertain. Aim: To determine whether short (≤96 hours) antibiotic treatment of uncomplicated CoNS sepsis in premature infants admitted to a neonatal intensive care unit is noninferior to long treatment (>96 hours) by comparing relapse rates. Methods: This multicenter, observational cohort study reviewed all proven neonatal CoNS sepsis in premature births Staphylococcus lugdunensis bacteremia. Data on patient characteristics, antibiotic treatment and relapse rates were systematically collected. The incidence of relapse (P noninferiority value 96 hours. Patient characteristics showed no significant differences. One relapse occurred in the short-treatment group (0.58%), none in the long-treatment group, with a significant P noninferiority value of 0.007. Conclusions: The relapse rate in uncomplicated CoNS sepsis was extremely low (<1%), even with short-course treatment. In premature infants with uncomplicated CoNS sepsis, shorter antibiotic treatment is noninferior to longer treatment, confirming its safety and effectiveness.

  • Potential change in healthcare costs of implementing artificial intelligence for detecting cervical spine fractures on CT: an early health technology assessment

    by Gaby J. van Den Wittenboer, Ingrid M. Nijholt, Ingelin Kvamme, Chris van Lieshout, Mario Maas, Martijn F. Boomsma

    Objectives To assess healthcare costs of patients screened for cervical spine (C-spine) fractures using CT, and estimate the change in in-hospital costs if an artificial intelligence (AI) algorithm for C-spine fracture detection would assist the radiologist as concurrent reader. Materials and methods This retrospective, early health technology assessment included 2321 consecutive patients (2007–2014; median age 49 years; 61% male) screened for C-spine fractures using CT, of whom 219 patients with fractures. Healthcare costs were calculated per diagnostic category (true positive, true negative, false positive and false negative) based on the diagnosis made by the attending radiologists, and by AI analysis, compared to the reference standard. The potential diagnostic accuracy measures with 95% confidence intervals (CI) for diagnoses made by radiologists assisted by AI and the potential average cost per diagnostic category in this scenario were estimated. Results Radiologists identified 193/219 fractures and 2085/2102 scans without fractures. AI identified 23 fractures and 16 scans without fractures that had been misclassified by the radiologists. This resulted in a potential sensitivity of 216/219 (98.6%, 95% CI: 95.7–99.6, 10.5% increase compared to radiologists) and specificity of 2101/2102 (100.0%, 95% CI: 99.7–100, 0.8% increase compared to radiologists) for the AI-assisted scenario. The total cost for the AI-assisted scenario was €60,862 (0.3%) higher than for radiologists alone. Conclusion In this scenario analysis, the addition of AI as concurrent reader to radiologists was estimated to potentially increase sensitivity by 10.5% and specificity by 0.8% together with a 0.3% increase in in-hospital costs due to more detected fractures. Key Points Question The impact of artificial intelligence to detect cervical spine fractures on CT on in-hospital healthcare resource use and costs is unknown. Findings Assistance by AI could potentially improve radiologists’ sensitivity and specificity by 10.5% and 0.8%, respectively, for an additional healthcare cost increase of just 0.3%. Clinical relevance Using artificial intelligence as concurrent reader to radiologists to detect cervical spine fractures on CT could potentially increase diagnostic accuracy to nearly 100% with a minimal increase in in-hospital healthcare resource costs. Graphical Abstract


  • Open Access

    Treatment of Uterine Fibroid–Related Heavy Menstrual Bleeding: Variations in Clinical Practice at Four Hospitals in the Netherlands

    by Elisabeth R. Knorren, Daniëlle P. C. Huijs, Ingrid M. Nijholt, Jeroen R. Dijkstra, F. Paul H. L. J. Dijkhuizen, Jan Willem van der Steeg, Tycho van der Meer, Martijn F. Boomsma, Maarten D. H. Vink, Peggy M. A. J. Geomini, et al.

    Introduction: Uterine fibroids are the most common anatomical cause of heavy menstrual bleeding. To which extent clinical practice variation is present in the treatment of fibroid‐related heavy menstrual bleeding at the hospital level remains unclear. The aim of this study was to identify and evaluate the clinical practice variation in the treatment of fibroid‐related heavy menstrual bleeding. Material and methods: In this multicenter, retrospective database study, pseudonymized real‐world data were collected from electronic health records using a natural language processing and text‐mining data collection tool. Women ≤ 55 years, who presented as new patients at the gynecology outpatient clinic in 2019 with heavy menstrual bleeding and fibroids, were selected. Data were extracted from the first appointment in 2019 throughout December 2022. The primary outcome was the number of treatments initiated. Secondary outcomes were the type of treatments initiated, treatments initiated prior to hysterectomy, and time to hysterectomy. Results: From four hospitals, 623 women were included. The median age was 46 (range: 23–55) years. Overall, a median of one treatment (range: 1–4) was initiated, which significantly differed between hospitals ( p < 0.01). Pharmacological treatment was initiated most frequently, which differed significantly among hospitals (392/623 [62.9%], range: 49.1%–70.5%, p = 0.02). Minimally invasive therapies were initiated in 51.2% (319/623, range: 40.6%–58.9%, p < 0.01). Only 30/319 patients (9.4%) received a minimally invasive uterus‐sparing treatment. Hysterectomy was performed in 123/319 patients (38.6%), with Hospital 1 being an outlier as 52.3% underwent hysterectomy, compared to 23.9%–36.4% in the other hospitals ( p < 0.01). Conclusions: Clinical practice variation is present in the treatment of heavy menstrual bleeding in Dutch women with fibroids. Organizational factors could partially explain clinical practice variation. Sharing data can aid in identifying, explaining, and acting on (un)warranted practice variation between healthcare clinics. While clinical practice variation remains inevitable, unwarranted practice variation should be limited by ameliorating guideline adherence, educational interventions, and patient counseling, to improve the quality, efficiency, and equity of care.

  • Open Access

    Cost-utility of focused ultrasound compared to radiotherapy for Dutch patients with uncomplicated non-spinal bone metastases

    by Julia Simões Corrêa Galendi, Ingrid Nijholt, Renée Hovenier, Jorik Slotman, Erik Phernambucq, Stephanie Stock, Clemens Bos, Manon Braat, Helena Verkooijen, Martijn Boomsma, et al.

    Introduction: Non-randomized clinical trial has shown that Magnetic Resonance guided High-intensity focused ultrasound (MR-HIFU) leads to faster pain relief compared to the current standard of care External Beam Radiotherapy (EBRT). Objective: To evaluate the cost-utility of ’early MR-HIFU’ (with optional EBRT afterwards) or ‘delayed MR-HIFU’ (i.e., MR-HIFU after failed EBRT) versus EBRT (with optional re-irradiation with EBRT) from the societal perspective in the Netherlands Methods: A lifelong patient-level simulation model was developed. After a treatment with either MR-HIFU or EBRT, a patient could have: (i) complete pain relief, (ii) partial pain relief, (iii) persistent pain and (iv) death. We also accounted for the event of a pathological fracture. Model outputs were costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICER). The net monetary benefit was calculated considering the willingness-to-pay threshold of €80,000 per QALY gained, adjusted by the Dutch disease severity index. Deterministic and probabilistic sensitivity analyses were conducted. Results: The strategy ‘delayed MR-HIFU’ costs €706 more than EBRT, whilst ‘early MR-HIFU’ costs €1,875 more than EBRT.‘Early MR-HIFU’ adds 0,15 more QALYs than EBRT, resulting in an ICER of €12.755 per QALY and an incremental net monetary benefit of €8,631. At a threshold of 80,000€ per QALY there is a 77% probability that ‘early MR-HIFU’ is the most cost-effective option. Conclusion: Although there are still uncertainties relating to implementation of MR-HIFU in patient care, our modelling study shows that offering MR-HIFU as an early treatment would be the most cost-effective option in the Netherlands.


  • Open Access

    Thrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial

    by W.J.E. Stenger, C.A. Den Uil, W.J.R. Rietdijk, I. Al Amri, J.M. Montero-Cabezas, C.V. Elzo Kraemer, T.E. van Mens, C.L. Meuwese, N.M.D.A. van Mieghem, M.N. Lauw, et al.


  • Open Access

    Trends in Term-Equivalent Age Brain Volumes in Infants Born Across the Gestational Age Spectrum

    by Anouk S. Verschuur, Gerda van Wezel-Meijler, Selma Low, Ingrid M. Nijholt, Amy Metcalfe, Janice Skiffington, Donna M. Slater, Amy Bergeron, Elsa Fiedrich, Martijn F. Boomsma, et al.

    Purpose: Our understanding of the influence of preterm birth and related perinatal exposures on early brain development is limited, hampering personalized optimization of neuroprotective strategies. This study assesses the effect of gestational age (GA) at birth on brain volumes at term-equivalent age (TEA) in infants without overt brain injury born across the GA spectrum. Methods: A cohort of infants born across the GA spectrum (25–40 weeks’ gestation) underwent 3T brain MRI around TEA (40–46 weeks postmenstrual age). Eight brain regions, intracranial and total tissue volumes were segmented using MANTiS (morphologically adaptive neonatal tissue segmentation toolbox). Segmentations were visually quality-checked and excluded if segmentation failed. Absolute TEA volume in relation to GA was assessed using univariate and multivariate (correction for postmenstrual age) linear regression analysis. Statistical significance was set at p < 0.05. Post hoc scatter plots of brain volumes relative to intracranial volumes were created. Results: Fifty infants were included (mean GA = 35.0 [SD = 3.3, range = 25.7–40.1] weeks). A higher GA at birth was significantly related to lower cerebrospinal fluid (p = 0.004) and amygdala (p = 0.02) volumes; no significant relation was found between GA and other volumes. Post hoc analyses showed positive trends between GA and several brain structures, including total brain tissue, cortical gray matter, deep gray matter, hippocampus, cerebellum and brainstem volumes. Conclusions: Our results suggest that GA has an effect on TEA brain volumes that is independent of brain lesions, with lower GA being associated with smaller brain tissue volumes and significantly larger cerebrospinal fluid volume. Preterm birth and related exposures may thus affect early brain growth and contribute to neurodevelopmental challenges encountered by preterm-born children.


  • Open Access

    Eligibility for Magnetic Resonance‐Guided High Intensity Focused Ultrasound in Patients Referred for Radiotherapy on Painful Nonspinal Bone Metastases

    by Renée Hovenier, Derk J. Slotman, Chiara Gasperini, Alice Zamagni, Mira Huhtala, Manon N. G. J. A. Braat, Wietse S. C. Eppinga, Nicolien Kasperts, Erik C. J. Phernambucq, Martijn F. Boomsma, et al.

    Purpose: This prospective observational study aims to investigate which proportion of patients with bone metastases referred for External Beam Radiation Therapy (EBRT) would be able to undergo Magnetic Resonance‐guided High Intensity Focused Ultrasound (MR‐HIFU) as alternative to EBRT, and to examine reasons for ineligibility. Materials and Methods: Adult patients with nonspinal bone metastases referred to four radiotherapy departments were included. Local, multidisciplinary teams assessed which patients would be eligible for MR‐HIFU. The main reason(s) for ineligibility were categorized as patient‐related or lesion‐related. A random subsample of 30 ineligible patients were analyzed in detail to identify all reasons of ineligibility. Results: Overall, 57 of 741 (8%) nonspinal bone lesions were eligible for MR‐HIFU as alternative to EBRT. In total, 153 lesions (21%) in 130 patients were ineligible because of patient‐related factors, including curative treatment intent for oligo‐metastatic disease (10%), and poor performance status (8%). Of the remaining 588 bone metastases in 526 patients, 531 lesions (470 patients) were ineligible because of lesion‐related factors, including ‘lesion too extensive/advanced’ (29%), ‘(impending) pathological fracture’ (15%), ‘no moderate/severe pain from target lesion’ (11%). Proportion of ineligibility varied between centers from 70% to 96%, which was mainly attributable to differences in patient‐related factors. Within the random subsample of 30 ineligible patients, 27 patients had multiple reasons for ineligibility. Conclusion: A small proportion of patients, referred for EBRT of bone metastases, would be eligible to undergo MR‐HIFU as alternative palliation option. Taken together, patients presenting with small, localized lesions in nonspinal regions, primarily seeking pain relief without additional treatment goals are the most promising candidates for this therapy. These factors could be used to triage patients eligible for MR‐HIFU, thereby reducing unnecessary screening efforts, enhancing patient selection, and ultimately improve patient management strategies by optimizing the use of MR‐HIFU as a treatment option.


  • Image-guided point-shear-wave elastography: a valid and reliable technique for liver fibrotic staging

    by Sietske Bergsma, Margo van Gent, Alida J. Dam-Vervloet, Martine C. M. Lagerweij, Egbert-Jan van der Wouden, Ingrid M. Nijholt, Martijn F. Boomsma, Lieke Poot

    Purpose Despite progressive implementation of image-guided point-shear wave elastography (pSWE) in guidelines as an alternative to transient elastography for the staging of fibrotic liver disease, pSWE is not widely adopted in clinical workflow. More information on reliability and validity of pSWE systems is needed. Therefore, we performed a phantom study to evaluate the validity and reliability of pSWE with ultrasound systems. Methods Validity and reliability of pSWE measurements from three ultrasound systems were evaluated. Measurements were performed on an elasticity phantom with reference elasticities of 7 ± 1 (low) (median ± interquartile range (IQR)), 14 ± 2 (medium) and 26 ± 3 (high) kPa. Measurements were repeated in tenfold for each reference at 2, 3 and 4 cm depth. Results were considered valid when median elasticity ± IQR was between the uncertainty limits (IQR) for each reference elasticity value and reliable when IQR/median < 0.30. Results pSWE with the systems provided valid results for all reference elasticities and focal depths, except for overestimation of high reference elasticity at 2 and 4 cm depth for one system (41.5 ± 4.3 and 39.0 ± 1.2 kPa, respectively). Measurements were reliable with a maximum IQR/median of 0.13, well below the guideline of IQR/median < 0.30. Discussion The results support the use of pSWE as an alternative to invasive or non-image guided noninvasive techniques for liver fibrotic staging. Conclusions pSWE with ultrasound systems from different vendors is valid and reliable and can therefore be implemented to optimize clinical workflow by performing imaging and elastography simultaneously.